MicroVent® V3: The Respiratory Care Ecosystem
Redefining Respiratory Care with Hardware × Software × Data
“MicroVent® V3” is not just a ventilator; it is a self-evolving “Respiratory Care Ecosystem” where the gas-powered hardware, a smartphone app, and a data platform function as one. By eliminating the need for electricity and simplifying operation, we bring advanced respiratory support to disaster zones, ambulances, and emerging nations—places where traditional ventilators cannot reach.
Estimated Potential Economic Value
Billions of JPY+ (Global Market Potential)
This valuation is based on the technology’s potential to capture vast, previously unaddressed markets:
Emergency Transport: Air ambulances, paramedics.
Disaster Medicine: Earthquake zones, conflict areas.
Emerging Nations: India, Africa, SE Asia (High volume, cost-sensitive).
The Core Innovation
The Challenge: Restricted Respiratory Care
Traditional ventilators have been severely limited by their dependence on electricity, high cost, and operational complexity. This created a critical gap, making life-saving technology unavailable where it was needed most.
STONY’s Solution: A Power-Free Open Ecosystem
We integrated three core elements to deliver respiratory care that can be used “anytime, anywhere, by anyone.”
Hardware (MicroVent® V3)
Power-Free: Operates purely on gas pressure. No battery anxiety.
Patented Safety: Equipped with our proprietary Relief Valve technology (JP/US/EU Patented) to prevent lung injury (Barotrauma).
Compact & Robust: Palm-sized, maintenance-free design.
Software (Setup Support App)
Acoustic Analysis: Analyzes operating sounds to visualize real-time respiratory rates and ventilation volumes.
Safe Operation: Ensures proper setup without expert knowledge, acting as a digital guide for non-specialists.
Data Platform
Real-world Evidence: A cyclical system where collected clinical data from the app becomes a source of value.
Future AI: Fueling future diagnostic AI and remote monitoring services for global health.
Development Stage & Regulatory Status
Unlike many startups, MicroVent® V3 is real and ready.
- Regulatory Approval: Japan PMDA Approved (Class III Medical Device).
- Manufacturing: Mass production line established at our “Mother Factory” (Tochigi Seiko Co., Ltd.) in Japan.
- Global IP: Patents granted in Japan, USA, Europe, and China.
Partnership Opportunity
We are currently seeking Global Licensing Partners for local manufacturing and sales (especially in India, Europe, and the US).
- Low Risk: No huge upfront R&D cost. We provide the “Blueprint” and “Mother Factory Standards.”
- High Return: Access a billion-dollar untapped market with a proven, approved device.